- Colfax Corp's (NYSE:CFX) price target has been lowered to $52 (an upside of 41%) from $60 by KeyBanc analyst Jeffrey Hammond, following ESAB/Enovis's 2022 Investor Day to reflect broadly lower peer multiples.
- The analyst maintained an Overweight rating on CFX shares.
- Related: Colfax's Q4 Earnings
- Morgan Stanley also lowered its price target on Colfax to $41 (an upside of 11%) from $45 while maintaining the Equal-Weight ratings on the shares.
- Colfax recently announced the future composition of the board of the company, which will be renamed Enovis Corp., upon the consummation of the company's previously announced spin-off of its existing fabrication technology business, which will operate as ESAB Corp.
- Colfax revealed an expected completion date of April 4, 2022, for the spin-off of ESAB Corp.
- Price Action: CFX shares are trading higher by 1.97% at $36.77 on the last check Tuesday.
